Medical Collagen Market Size, Share, Growth and Industry Analysis by Type (Collagen Powder, And, Collagen Fluid), By Application (Collagen - Based Bone Graft Replacement, Wound Dressing, Skin Substitute, And, Cosmetic Facial Skin Implants) Regional Forecast to 2028

Updated On: 22 April 2024

REPORT OVERVIEW

• 

• Request a Free Sample to learn more about this report

The global medical collagen market size is anticipated to be worth USD 215.3 million in 2021. The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. As per our research, the market is projected to touch USD 396.3 million by 2028 with a CAGR of 9.0% during the forecast period. The sudden spike in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.

Medical collagen, a vital protein found abundantly in our bodies, plays a crucial role in various medical applications. Renowned for its structural support, it is widely utilized in wound healing, tissue engineering, and cosmetic surgeries. Medical collagen's biocompatibility and bioactive properties make it an ideal component in the development of scaffolds and implants, promoting tissue regeneration and enhancing overall patient outcomes.

Collagen has properties like improved biocompatibility, increased stability, and controlled release capabilities. Rising prevalence of chronic wounds, and, rising consumer awareness about the benefits of collagen will promote market growth. All of these factors have played an important role in increasing the medical collagen market growth.

COVID-19 Impact: Usage of Collagen in Medical Advancements During Pandemic Improved Market Growth

The pandemic of COVID-19 was unprecedented and became the biggest problem for manufacturers, retailers, and entrepreneurs. The pandemic disrupted global supply chains, leading to potential shortages of collagen-based medical products. Manufacturing delays and restrictions also affected the availability of collagen-based wound dressings, tissue-engineered constructs, and other medical applications.

 Furthermore, the increased demand for personal protective equipment (PPE) during the pandemic put pressure on collagen suppliers and manufacturers. However, the ongoing research into COVID-19 therapies has highlighted the potential of collagen-based materials in drug delivery systems and vaccine development. Despite the challenges faced, the pandemic has emphasized the importance of collagen in medical advancements and underscored the need for resilient supply chains to support future healthcare needs.

LATEST TRENDS

"Superior Qualities of Medical Collagen to Increase Market Growth"

The medical collagen market has witnessed a notable trend in recent times with the emergence of advanced collagen-based biomaterials. Researchers and manufacturers are focusing on developing innovative collagen products with enhanced properties, such as improved biocompatibility, increased stability, and controlled release capabilities.

Additionally, there is a growing interest in utilizing collagen from sustainable and ethically sourced animal or plant-derived alternatives. This shift towards eco-friendly collagen sources aligns with the increasing demand for natural and environmentally conscious healthcare solutions. Furthermore, the incorporation of collagen in regenerative medicine, including tissue engineering and organ transplantation, continues to drive the market's growth as it offers promising avenues for advanced therapies and personalized medicine. This is considered as the latest trend in the market.

SEGMENTATION

• 

• Request a Free Sample to learn more about this report

• By Type:

The market can be divided on the basis of type as follows:

Collagen powder, and, collagen fluid. The collagen powder segment is expected to hold the dominant market share through 2028.

• By Application:

Classification based on application is as follows:

Collagen - based bone graft replacement, wound dressing, skin substitute, and, cosmetic facial skin implants. The collagen- based bone graft replacement segment is predicted to dominate the market through 2028.

DRIVING FACTORS

"Rising Prevalence of Chronic Diseases to Amplify Market Growth"

The collagen market is primarily driven by several key factors. Firstly, the rising prevalence of chronic wounds, such as diabetic ulcers and pressure sores, fuels the demand for collagen-based wound dressings and healing therapies. Secondly, the growing aging population worldwide contributes to the market expansion as collagen plays a vital role in maintaining skin elasticity and joint health, leading to an increased demand for cosmetic and orthopedic applications.

Additionally, advancements in tissue engineering and regenerative medicine further boost the market, with collagen being a preferred biomaterial for scaffold production and tissue regeneration. Lastly, increasing research and development activities, coupled with technological innovations, pave the way for novel collagen-based products, propelling market growth.

"Usage of Collagen in Cosmetic Procedures to Accelerate Market Development "

In addition to the factors mentioned earlier, several other driving forces propel the growth of the collagen market. One such factor is the rising consumer awareness about the benefits of collagen supplementation in promoting skin health, hair growth, and joint mobility. This has led to an increased demand for collagen-based dietary supplements and nutraceuticals. Furthermore, the expanding applications of collagen in the pharmaceutical industry, including drug delivery systems and tissue engineering, contribute to market growth.

 Also, the growing adoption of collagen in cosmetic procedures, such as dermal fillers and facial rejuvenation treatments, fuels the market expansion. Moreover, collaborations and strategic partnerships among key industry players and research institutions drive innovation and product development, further boosting the medical collagen market share.

RESTRAINING FACTOR

"Stringent Approval Process for Collagen Medical Products to Bring Down Market Growth"

While the medical collagen market exhibits strong growth potential, it faces certain restraining factors. One significant factor is the high cost associated with the production and purification of medical-grade collagen, limiting its accessibility, especially in developing regions. Challenges and stringent approval processes for collagen-based medical products pose barriers to market entry.

Moreover, ethical concerns related to animal-derived collagen sources raise questions about sustainability and animal welfare. The limited availability of skilled professionals proficient in collagen-based research and development also hampers market growth.

Regional Insights

• 

• Request a Free Sample to learn more about this report

"North America to Dominate Market Growth During Forecast Period"

North America emerges as the leading region in the medical collagen market. The region's prominence can be attributed to several factors. Firstly, the well-established healthcare infrastructure and advanced research capabilities contribute to the development and commercialization of collagen-based medical products.

Secondly, the high prevalence of chronic diseases, such as diabetes and obesity, drives the demand for wound care and regenerative medicine solutions. Furthermore, the growing focus on aesthetics and the popularity of cosmetic procedures in the region fuel the demand for collagen-based dermal fillers and facial rejuvenation treatments. Lastly, supportive government initiatives, favorable reimbursement policies, and a strong presence of key market players further consolidate North America's position as a leading region in the collagen market.

Key Industry Players

"Leading Players adopt Acquisition Strategies to Stay Competitive "

Several players in the market are using acquisition strategies to build their business portfolio and strengthen their market position in the recent days. In addition, partnerships and collaborations are among the common strategies adopted by companies. Key market players are making R&D investments to bring advanced technologies and solutions to the market. Key market players have adopted unique strategies to flourish in the market.

List of Market Players Profiled

• DSM (Netherlands)
• Integra LifeSciences (U.S.)
• Collagen Matrix (U.S.)
• Encoll (U.S.)
• Stryker (U.S.)
• Collagen Solutions (U.K.)
• Innocoll GmbH (Germany)
• Symatese (France)
• Sunmax (China)
• Victory Biotech Co., Ltd. (China)
• TaikeBio (China)
• Trauer (Germany)

Report Coverage

The report provides an insight into the industry from both the demand and supply sides. Further, it also gives information on the impact of COVID-19 on the market, the driving and the restraining factors along with the regional insights. Market dynamic forces during the forecast period have also been discussed for the better understanding of the market situations